Outcomes in systemic lupus erythematous (SLE) patients treated with belimumab in clinical practice settings: results from the observe study in switzerland

被引：0
|
作者：
von Kempis, J. [1 ]
Dutsch, S. [2 ]
Reuschling, N. [1 ]
Villiger, R. [3 ]
Vallelian, F. [4 ]
Schaer, D. J. [4 ]
Mueller, R. B. [1 ]
机构：
[1] Kantonsspital St Gallen, St Gallen, Switzerland
[2] GlaxoSmithKline AG, Munchenbuchsee, Switzerland
[3] Inselspital Bern, Bern, Switzerland
[4] Univ Spital Zurich, Zurich, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2017年 / 147卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 3
引用
收藏
页码：4S / 4S
页数：1
相关论文
共 50 条
  • [11] Outcomes Associated with Belimumab in Black/African American Patients with Systemic Lupus Erythematous in Clinical Practice Settings in the United States
    Collins, Christopher E.
    Narayanan, Siva
    Dall'Era, Maria
    Dennis, Greg
    Oglesby, Alan
    McGuire, Mark B.
    Pappu, Ramesh
    Molta, Charles T.
    Keenan, Greg
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1109 - S1109
  • [12] OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH HIGH DISEASE ACTIVITY TREATED WITH BELIMUMAB: 18 MONTH RESULTS FROM THE US OBSERVE STUDY
    Collins, C. E.
    Dall'Era, M.
    Macahilig, C.
    Pappu, R.
    Molta, C.
    Kan, H.
    Koscielny, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 522 - 522
  • [13] Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina
    Babini, A.
    Cappuccio, A. M.
    Caprarulo, C.
    Casado, G.
    Eimon, A.
    Figueredo, H.
    Garcia, M. A.
    Magri, S.
    Mannucci, P.
    Perez Rodriguez, S.
    Pons-Estel, B. A.
    Velozo, E. J.
    Iglesias-Rodriguez, M.
    Streger, G.
    LUPUS, 2020, 29 (11) : 1385 - 1396
  • [14] 24-Month Outcomes Associated with Belimumab in Patients with Systemic Lupus Erythematosus in Clinical Practice Settings
    Collins, Christopher E.
    Kan, Hong
    Dall'era, Maria
    Macahilig, Cynthia
    Pappu, Ramesh
    Molta, Charles T.
    Koscielny, Volker
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S291 - S291
  • [15] Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
    Cortes-Hernandez, Josefina
    Marras Fernandez-Cid, Carlos
    Andreu Sanchez, Jose Luis
    Calvo Alen, Jaime
    Garcia-Aparicio, Angel M.
    Diez Alvarez, Elvira
    Hidalgo Bermejo, Francisco Javier
    Coronell, Carlos
    Perna, Alessandra
    Ordi Ros, Josep
    REUMATOLOGIA CLINICA, 2023, 19 (06): : 312 - 318
  • [16] Belimumab 24-month treatment outcomes in patients with systemic lupus erythematosus (SLE) with high disease activity: Results from the OBSErve real-world study
    Collins, C.
    Dall'Era, M.
    Macahilig, C.
    Molta, C.
    Kan, H.
    Koscielny, V.
    Chang, D. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S28 - S28
  • [17] Belimumab in systemic lupus erythematosus: Experience in clinical practice settings in a regional hospital
    Riancho-Zarrabeitia, Leyre
    Villa Blanco, Ignacio
    Santos-Gomez, Montserrat
    Aurrecoechea, Elena
    REUMATOLOGIA CLINICA, 2020, 16 (02): : 188 - 190
  • [18] Effect of Belimumab Treatment on Renal Outcomes: Results From Phase 3 Belimumab Clinical Trials in Patients with Systemic Lupus Erythematosus
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, Anca D.
    Roth, D.
    Zhong, Z. J.
    Freimuth, W.
    Ginzler, E. M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S963 - S964
  • [19] Different pregnancy outcomes in patients with systemic lupus erythematosus treated with belimumab
    Lai, Yupeng
    Li, Bin
    Huang, Jiaming
    Du, Jingning
    Yue, Mengli
    Shen, Xin
    Liu, Xingjiao
    Huang, Lingfeng
    Lin, Jiehua
    Yang, Aicheng
    Wang, Meiying
    LUPUS, 2023, 32 (01) : 149 - 154
  • [20] First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study
    Schwarting A.
    Schroeder J.O.
    Alexander T.
    Schmalzing M.
    Fiehn C.
    Specker C.
    Perna A.
    Cholmakow-Bodechtel C.
    Koscielny V.B.
    Carnarius H.
    Rheumatology and Therapy, 2016, 3 (2) : 271 - 290
12345